Category

NASDAQ

Canaccord Genuity Maintains Intercept Pharmaceuticals (ICPT) Hold Recommendation NASDAQ

Canaccord Genuity Maintains Intercept Pharmaceuticals (ICPT) Hold Recommendation

Fintel reports that on May 23, 2023, Canaccord Genuity maintained coverage of Intercept Pharmaceuticals (NASDAQ:ICPT) with a Hold recommendation. Analyst Price Forecast Suggests 160.70% Upside As of May 11, 2023, the average one-year price target for Intercept Pharmaceuticals is 24.84. The forecasts range from a low of 12.12 to a…
bubmag
May 23, 2023
Market Snapshot: Megacap tech stocks out of control? Big Tech still has the power to extend the rally and weather an economic storm, analysts say. NASDAQ

Market Snapshot: Megacap tech stocks out of control? Big Tech still has the power to extend the rally and weather an economic storm, analysts say.

Megacap technology stocks have dominated the U.S. stock market performance this year, powering the Nasdaq Composite to a new nine-month high last week as investors have loaded up on them in a “safe-haven play” on concerns over a potential recession, a federal debt-ceiling breach and more stress in regional banks.…
bubmag
May 22, 2023
Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference NASDAQ

Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference

BOSTON, MA / ACCESSWIRE / May 21, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, announced the presentation of preclinical data from the Company's inhaled connective tissue growth factor (CTGF) antagonist program,…
bubmag
May 21, 2023
Airbnb’s Warning Sign: Is Management About to Make a Big Mistake? NASDAQ

Airbnb’s Warning Sign: Is Management About to Make a Big Mistake?

Putin, Russia ‘Seriously Damaged’ by Events: Ex-Ambassador Former British Ambassador to Russia Laurie Bristow examines the fallout from Wagner chief Yevgeny Prigozhin's advance toward Moscow on President Vladimir Putin, Russia’s global standing, and the war in Ukarine. He speaks with Francine Lacqua on “Bloomberg Surveillance Early Edition.” Jun 26, 2023…
bubmag
May 21, 2023
Envirotech Vehicles Announces Receipt of Expected Notice from Nasdaq Related to Delayed Filing of Form 10-Q NASDAQ

Envirotech Vehicles Announces Receipt of Expected Notice from Nasdaq Related to Delayed Filing of Form 10-Q

OSCEOLA, AR / ACCESSWIRE / May 19, 2023 / Envirotech Vehicles, Inc. (NASDAQ:EVTV), ("EVTV" or "the Company"), announced today that it received a notification letter from the Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet…
bubmag
May 19, 2023
ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights NASDAQ

ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights

Received FDA clearance for investigational new drug (IND) application for lead therapeutic candidate, PMN310, in Alzheimer’s disease Presented preclinical data supporting target identification and candidate differentiation across pipeline of antibody therapeutics at international neurology conferences “In the first quarter, we completed the required steps that enabled us to file our…
bubmag
May 16, 2023
HC Wainwright & Co. Reiterates Longboard Pharmaceuticals (LBPH) Buy Recommendation NASDAQ

HC Wainwright & Co. Reiterates Longboard Pharmaceuticals (LBPH) Buy Recommendation

Fintel reports that on May 12, 2023, HC Wainwright & Co. reiterated coverage of Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy recommendation. Analyst Price Forecast Suggests 95.93% Upside As of May 11, 2023, the average one-year price target for Longboard Pharmaceuticals is 17.08. The forecasts range from a low of 11.11…
bubmag
May 13, 2023